Nanofiber Quantum Technologies, Inc.
PALO ALTO, CA / ACCESSWIRE / September 15, 2023 / Nanofiber Quantum Technologies Inc. ("NanoQT") raised $8.5m from leading venture capital investors. Phoenix Venture Partners (PvP) in the US, and Japan's JAFCO Group Co Ltd, SPARX Group Co Ltd, Keio Innovation Initiative, Inc. (KII), and Waseda University Ventures (WUV) financed the round through convertible notes.
Founded in 2022, NanoQT is a leading startup company focused on fiber connectable quantum computing hardware. Unlike superconducting circuits and ion traps for quantum computing, NanoQT uses a technology called nanofiber cavity Quantum Electrodynamics (QED). This technology has been derived from over a decade of intensive research by Professor Takao Aoki at Waseda University, Japan, a leading expert in quantum computing and co-founder of NanoQT.
NanoQT owns a novel and proprietary quantum processing unit (QPU) that employs neutral atoms and photons as qubits, capable of processing and storing quantum information while communicating with other QPUs. Modularity and scalability of interconnected QPUs offer a unique platform for distributed quantum computing and quantum networks for a variety of useful applications. NanoQT's QPU aims to revolutionize quantum computing.
"While cavity QED has long been a recognized platform in quantum computing, developing the ideal cavity posed significant challenges. We've overcome these challenges using our proprietary QED technology," comments Dr. Akihisa Goban, NanoQT's CTO and co-founder, who studied cavity QED technologies under Professor Jeff Kimble at Caltech.
"We are thrilled with the support from our US and Japanese investors. We aim to spotlight our unique approach and its strengths. With the funding, our primary objective is to develop our proprietary QPU for quantum repeaters, an innovation not yet seen in the market," proclaims Dr. Masashi Hirose, NanoQT's CEO and co-founder, an MIT graduate and former McKinsey and Company consultant.
"For PvP, investing in NanoQT isn't merely another venture investment. This is our first investment in a Japan-origin startup. We are deeply impressed by NanoQT's innovative approach in the quantum hardware sector and are pleased to support their US expansion," expresses Dr. Nobi Kambe, General Partner of PvP.
"Our confidence in NanoQT's potential comes from its leadership. The investment is rooted in our belief in NanoQT's management team led by Dr. Hirose and Dr. Goban. We're confident they can assemble a global team well beyond Japan," comments Keisuke Miyoshi, the President and CEO of JAFCO.
Takaki Demichi, Director and Head of Mirai Creation Investment (SPARX), has a similar sentiment. "NanoQT's distinct approach doesn't just introduce novelty. It crucially addresses the longstanding challenge of connectivity, enhancing the scalability of quantum computers."
Naoji Nomura, Principal of KII, emphasizes that "NanoQT is an outstanding startup with extremely high potential for the global social implementation of moonshot-class quantum network technology, developed over many years at Japanese universities."
Dr. Hiroaki Ohta, General Partner of WUV, mentioned, "We are delighted to invest again, having supported NanoQT since the seed round. NanoQT has shown significant growth, especially in terms of collaborations, the R&D team, and intellectual property, which are fundamental for a hardware startup."
Fueled by this funding, NanoQT plans to accelerate its R&D, onboard talent from the US and Japan, and foster collaborations with academia and private corporations. With the Japan-US synergy, armed with cutting-edge technology, and oriented towards US-Japan collaborations, NanoQT aspires to exemplify global collaboration in the quantum computing field.
About Nanofiber Quantum Technologies, Inc.
Nanofiber Quantum Technologies (NanoQT) is a technology company that develops quantum processing units (QPU) using a novel and proprietary nanofiber cavity Quantum Electrodynamics (QED) system. NanoQT aims to develop connected QPUs that operate as quantum repeaters and distributed computational units. NanoQT currently operates in Tokyo, Japan, and California, US.
Nanofiber Quantum Technologies, NanoQT, and logo are trademarks of Nanofiber Quantum Technologies, Inc.
Contact Information
Dai Tsukada
Head of Operations
info@nano-qt.com
SOURCE: Nanofiber Quantum Technologies Inc.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/782714/quantum-computing-startup-nanofiber-quantum-technologies-secures-85m-funding
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
15 Companies Pitch Their Capabilities at GA-ASI’s Blue Magic Netherlands2.12.2024 13:00:00 CET | Press release
Nov. 19 Event Hosted by GA-ASI and Supported by Lockheed Martin Ventures and Brainport Attracts Cross-Section of Netherlands' High-Tech Sector SAN DIEGO, CA / ACCESSWIRE / December 2, 2024 / On November 19, 2024, General Atomics Aeronautical Systems, Inc. (GA-ASI) hosted its first Blue Magic Netherlands (BMN) event in Eindhoven, the Netherlands. Approximately 200 people attended the event that provided Dutch businesses with an opportunity to present their capabilities to GA-ASI and other companies interested in possible collaborations. GA-ASI was joined for the event by the Netherlands Ministry of Economic Affairs, the Netherlands Ministry of Defence, Lockheed Martin Ventures, Brainport Development, Brabant Development Agency (BOM), the Netherlands Industries for Defence & Security (NIDV), and SpaceNED. At this event, GA-ASI and its partners heard first-hand from Dutch companies about the important capabilities they are developing. The process started in July when GA-ASI put out an ope
BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide2.12.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally identified as BNT24005. This innovative product is intended to address limitations of existing administration methods for a therapeutic developed by Novo Nordisk, with the aim of improving patient accessibility and convenience. This product is currently under development and remains subject to regulatory review and approval. Semaglutide: A Proven Therapeutic Leader Semaglutide, developed by Novo Nordisk and marketed under brand names such as Ozempic® and Wegovy®, has revolutionized treatment for Type 2 diabetes and obesity. By mimicking glucagon-like peptide-1 (GLP-1), it enhances insulin secretion, reduces appetite, and slows gastric emptying, offering powerful tools for glycemi
GoodData Launches FlexConnect: Connect to Any Data Source & Transform Data at Run-Time2.12.2024 03:00:00 CET | Press release
SAN FRANCISCO, CA / ACCESSWIRE / December 2, 2024 / Today, GoodData introduces FlexConnect, an advanced component of the GoodData Analytics Lake that redefines data connectivity and computation. FlexConnect enables organizations to: Connect to any data source, including APIs, databases, and ML systems. Execute custom computation logic directly into the data connection using Python, Rust, and other popular languages. Integrate transformed results into GoodData's FlexQuery for further BI computation Render results through any endpoint, GoodData's UI, your UI, or through our APIs and SDKs. "FlexConnect solves a longstanding problem for analytics teams by eliminating the need to wait for vendors to build integrations. With FlexConnect, you can build high-performance connections to a wide range of sources-cloud-based, on-premises, hybrid, SQL, NoSQL, APIs, or machine learning models," said Ryan Dolley, VP of Product Strategy at GoodData. FlexConnect's differentiation lies in its use of Apac
HotelRunner Triumphs as the 'Best Large Technology Supplier' at the Travolution Awards29.11.2024 04:00:00 CET | Press release
HotelRunner, the trailblazing platform for travel and hospitality technologies, has been named the ‘Best Large Technology Supplier' at the Travolution Awards 2024 in the United Kingdom. Selected by the esteemed Travolution Awards jury, this recognition underscores HotelRunner's commitment to innovation and excellence, driving the travel industry forward with data-driven, AI-powered solutions. LONDON, UK / ACCESSWIRE / November 29, 2024 / HotelRunner, the trailblazing platform for travel and hospitality technologies, has been awarded the prestigious "Best Large Technology Supplier" title at the Travolution Awards 2024. The event, held on Nov. 28 in London, celebrated leaders in travel and technology and recognized drivers of innovation and excellence. HotelRunner was selected by a globally respected jury from among six companies competing in the same category, including software companies, tour operator platforms, and SaaS providers. This award recognizes large travel tech companies tha
DEXIS Attends ADF, Showcases Award-Winning Solutions28.11.2024 09:30:00 CET | Press release
QUAKERTOWN, PA / ACCESSWIRE / November 28, 2024 / The latest AI-powered launches from DEXIS enhance diagnostics and patient care. At ADF, DEXIS showcased its innovative product line, including the new intraoral scanners and imaging products. The conference took place November 26-30 at the Palais des Congrès de Paris in Porte Maillot, France. The company's comprehensive range of award-winning solutions covers a complete digital diagnostic workflow, from intraoral scanning and implant planning to sensors, CBCT, and imaging software. With an expanded portfolio and ecosystem, DEXIS Solutions is designed to accelerate workflows, increase productivity, and improve the patient experience. "Our technology makes it easy to organize information and execute treatments, which is at the core of what clinicians expect from us," said DEXIS President, Robert Befidi. "We are connecting and standardizing the implant workflow while also constantly evaluating our efforts to ensure we provide deeper patien
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom